Informed and uninformed empirical therapy policies.


Journal

Mathematical medicine and biology : a journal of the IMA
ISSN: 1477-8602
Titre abrégé: Math Med Biol
Pays: England
ID NLM: 101182345

Informations de publication

Date de publication:
10 09 2020
Historique:
received: 07 05 2019
revised: 16 07 2019
accepted: 02 10 2019
pubmed: 27 12 2019
medline: 13 7 2021
entrez: 27 12 2019
Statut: ppublish

Résumé

We argue that a proper distinction must be made between informed and uninformed decision making when setting empirical therapy policies, as this allows one to estimate the value of gathering more information about the pathogens and their transmission and thus to set research priorities. We rely on the stochastic version of a compartmental model to describe the spread of an infecting organism in a health care facility and the emergence and spread of resistance to two drugs. We focus on information and uncertainty regarding the parameters of this model. We consider a family of adaptive empirical therapy policies. In the uninformed setting, the best adaptive policy allowsone to reduce the average cumulative infected patient days over 2 years by 39.3% (95% confidence interval (CI), 30.3-48.1%) compared to the combination therapy. Choosing empirical therapy policies while knowing the exact parameter values allows one to further decrease the cumulative infected patient days by 3.9% (95% CI, 2.1-5.8%) on average. In our setting, the benefit of perfect information might be offset by increased drug consumption.

Identifiants

pubmed: 31875921
pii: 5686327
doi: 10.1093/imammb/dqz015
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

334-350

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Institute of Mathematics and its Applications. All rights reserved.

Auteurs

Nicolas Houy (N)

University of Lyon, Lyon, F-69007, France.
CNRS, GATE Lyon Saint-Etienne, F-69130, France.

Julien Flaig (J)

University of Lyon, Lyon, F-69007, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH